(WBA) were valued at $84.51 and moved -0.53% as of a recent closing trade. This is an increase of 300% compared to the typical volume of 174 put options.
(PENN) stock moved with shift of 2.25% in the past week. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Atlantic Equities raised its rating on Walgreens Boots Alliance, Inc.to Overweight on 06/02/2017 in a reversal from its prior Neutral rating. MD now owns 39,319,406 shares of the pharmacy operator’s stock valued at $3,169,931,000 after buying an additional 10,206,621 shares during the last quarter.
Currently, the market capitalization of Walgreens Boots Alliance, Inc. Newman Dignan & Sheerar Inc. now owns 5,430 shares of the pharmacy operator’s stock valued at $438,000 after buying an additional 75 shares during the last quarter. Thomaspartners Inc. now owns 4,357 shares of the pharmacy operator’s stock valued at $351,000 after buying an additional 20 shares in the last quarter. Finally, Lazard Asset Management LLC boosted its stake in Walgreens Boots Alliance by 138.3% in the third quarter. Shares have risen 0.88% over the trailing 6 months. Values of %D line that are above 80 indicate that the security is overbought; prices could well fall in the near future. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price.
WBA has been the subject of several research reports.
Analysts gives AES Corp (NYSE:AES) a mean recommendation of 2.50. Robert W. Baird restated an “outperform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, January 24th. For now, Walgreens Boots Alliance, Inc.is the toast of Wall Street as its ABR stands at 2.00 with 9 out of 25 analysts rating the stock a buy. Nordea Investment Management AB boosted its stake in shares of Walgreens Boots Alliance by 4,480.8% in the third quarter.
In terms of Buy, Sell or Hold recommendations, Walgreens Boots Alliance (NASDAQ:WBA) has analysts’ mean recommendation of 2. The stock has a consensus rating of “Buy” and an average price target of $91.77. The stock hit its 52-week high on 02/21/17, and 52-week low on 10/19/16. Recently, the stock has been noticed trading 1.13% away from the 20-day moving average. The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, April 5th. Sure, the percentage is discouraging but better times are ahead as looking out over a next 5-year period, analysts expect the company to see its earnings go up by 4.84%, annually. For the current year the company’s revenue estimates are $117.6 Billion compared to low analyst estimates of $115.14 Billion and high estimates of $122.8 Billion according to 21 number of analysts. However it has a net margin of 3.70%.
WBA’s revenue has grown at an average annualized rate of about 10.2% during the past five years.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 12th. In this case, shares are down -8.88% from $89.69, the 52-week high touched on February 21, 2017, and are keeping their losses at 8.33% for the past 12 months. The ex-dividend date of this dividend is Tuesday, May 16th. The stock’s Dividend Yield stands at 1.84%.
COPYRIGHT VIOLATION WARNING: “Traders Purchase High Volume of Put Options on Walgreens Boots Alliance (WBA)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another publication, it was copied illegally and republished in violation of worldwide copyright law. The legal version of this piece can be read at https://www.themarketsdaily.com/2017/05/19/walgreens-boots-alliance-wba-earning-positive-press-coverage-report-finds-updated.html.
Walgreens Boots Alliance, Inc.is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. This Beta value of Walgreens Boots Alliance, Inc. The company’s market cap is $88.3 Billion.